X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (642) 642
Publication (50) 50
Patent (32) 32
Book / eBook (11) 11
Book Review (10) 10
Dissertation (6) 6
Magazine Article (3) 3
Book Chapter (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (219) 219
index medicus (187) 187
female (169) 169
male (158) 158
middle aged (128) 128
aged (94) 94
adult (93) 93
risk factors (67) 67
oncology (61) 61
spain (55) 55
cancer (47) 47
medical and health sciences (46) 46
medicin och hälsovetenskap (46) 46
clinical medicine (45) 45
case-control studies (44) 44
risk (44) 44
analysis (43) 43
klinisk medicin (40) 40
research (40) 40
spain - epidemiology (38) 38
prospective studies (37) 37
epidemiology (36) 36
cancer and oncology (32) 32
cancer och onkologi (32) 32
medicine (31) 31
genetic predisposition to disease (29) 29
multidisciplinary sciences (29) 29
cohort studies (28) 28
public, environmental & occupational health (28) 28
infectious diseases (27) 27
polymorphism, single nucleotide (27) 27
genotype (26) 26
health aspects (26) 26
aged, 80 and over (25) 25
hematology (24) 24
research article (24) 24
genetic aspects (23) 23
biomarkers (22) 22
europe (22) 22
expression (22) 22
incidence (22) 22
magnetic resonance imaging (21) 21
adolescent (20) 20
association (20) 20
child (20) 20
immunology (20) 20
studies (20) 20
breast cancer (19) 19
child, preschool (19) 19
diagnosis (19) 19
gastric cancer (19) 19
genes (19) 19
mortality (19) 19
neurosciences (19) 19
age (18) 18
science (18) 18
stomach neoplasms - genetics (18) 18
young adult (18) 18
article (17) 17
genetic susceptibility (17) 17
hospitals (17) 17
prognosis (17) 17
public health (17) 17
regression analysis (17) 17
animals (16) 16
disease (16) 16
disease progression (16) 16
infant (16) 16
internal medicine (16) 16
mutation (16) 16
prevalence (16) 16
retrospective studies (16) 16
follow-up studies (15) 15
genetics (15) 15
microbiology (15) 15
care and treatment (14) 14
cross-sectional studies (14) 14
health risks (14) 14
oncology, experimental (14) 14
polymorphism (14) 14
polymorphism, genetic (14) 14
adenocarcinoma (13) 13
children (13) 13
genetic research (13) 13
medical research (13) 13
memory (13) 13
neurology (13) 13
odds ratio (13) 13
polymorphisms (13) 13
pregnancy (13) 13
screening (13) 13
stomach cancer (13) 13
ecology (12) 12
genetics & heredity (12) 12
infant, newborn (12) 12
neuropsychological tests (12) 12
patients (12) 12
peripheral vascular disease (12) 12
surveillance (12) 12
tumors (12) 12
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (530) 530
Spanish (167) 167
French (14) 14
German (12) 12
Catalan (9) 9
Portuguese (7) 7
Chinese (1) 1
Danish (1) 1
Estonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
BMC Cancer, ISSN 1471-2407, 02/2016, Volume 16, Issue 1, p. 135
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2019, Volume 14, Issue 1, p. e0210353
Journal Article
Journal Article
Medicine (United States), ISSN 0025-7974, 08/2016, Volume 95, Issue 32, p. e4507
Kidney injury (defined as the presence of albuminuria, proteinuria, glycosuria [without hyperglycemia], hematuria, and/or renal hypophosphatemia) is an... 
protease inhibitors | AIDS | HIV | nephrotoxicity | proteinuria | kidney impairment | MORTALITY | RENAL-FUNCTION | ANTIRETROVIRAL THERAPY | PREVALENCE | DAMAGE | HIV-INFECTED PATIENTS | MEDICINE, GENERAL & INTERNAL | COHORT | ATAZANAVIR | CHRONIC KIDNEY-DISEASE | TENOFOVIR | Acute Kidney Injury - urine | Biomarkers - urine | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | Atazanavir Sulfate - adverse effects | Proteinuria - chemically induced | Ritonavir - adverse effects | Darunavir - administration & dosage | Proteinuria - urine | Ritonavir - therapeutic use | Adult | Female | Acute Kidney Injury - chemically induced | Albuminuria - urine | HIV Protease Inhibitors - adverse effects | Cross-Sectional Studies | HIV Protease Inhibitors - therapeutic use | Atazanavir Sulfate - therapeutic use | Albuminuria - chemically induced | HIV Infections - drug therapy | Lopinavir - therapeutic use | HIV Infections - urine | Darunavir - therapeutic use | Lopinavir - adverse effects | Antiviral agents | Usage | Care and treatment | Dosage and administration | Kidney diseases | HIV (Viruses) | Observational studies | Risk factors | 92C Physiological, cellular and medical topics | 92 Biology and other natural sciences | Investigació operativa | Matemàtiques i estadística | Classificació AMS | Àrees temàtiques de la UPC
Journal Article
BMC Genomics, ISSN 1471-2164, 10/2015, Volume 16, Issue 1, p. 846
Journal Article
Pharmacogenomics, ISSN 1462-2416, 04/2016, Volume 17, Issue 5, pp. 463 - 471
We aimed to identify SNPs associated with cabazitaxel toxicity and response within a Phase II clinical trial using this compound in advanced transitional cell... 
SNPs | cabazitaxel | genitourinary transitional cell carcinoma | biomarkers | pharmacogenetics | OVARIAN-CANCER PATIENTS | ABCB1 | DOCETAXEL | P-GLYCOPROTEIN | PACLITAXEL | PHARMACOKINETICS | PROSTATE-CANCER | TAXANE | PHARMACOLOGY & PHARMACY | MULTIDRUG-RESISTANCE GENE | Humans | Middle Aged | Male | Tubulin - genetics | Antineoplastic Agents - therapeutic use | Urinary Bladder Neoplasms - drug therapy | Urothelium - pathology | Taxoids - therapeutic use | Neoplasm Metastasis | Urinary Bladder Neoplasms - genetics | Carcinoma, Transitional Cell - pathology | Cytochrome P-450 CYP3A - genetics | Antineoplastic Agents - adverse effects | Carcinoma, Transitional Cell - drug therapy | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Aged | Polymorphism, Single Nucleotide | Cytochrome P-450 CYP2C8 - genetics | ATP Binding Cassette Transporter, Sub-Family B - genetics | Taxoids - adverse effects | Carcinoma, Transitional Cell - genetics | Statistical analysis | Toxicity | Genomics | Genes | Glycoproteins | Genomes | Single-nucleotide polymorphism | Metastasis | FDA approval | Transitional cell carcinoma | Patients | Cancer therapies | Clinical outcomes | Ovarian cancer | Chemotherapy | Platinum | Cell cycle | Population | Genetic testing | Prostate cancer | Drug dosages | Deoxyribonucleic acid--DNA | Neutropenia | Index Medicus
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 02/2018, Volume 141, Issue 2, pp. AB149 - AB149
Methods Randomized, open-label, cross-over clinical trial, consecutively including anaphylaxis patients carrying an EIA. anAPPhylaxisTM is a patented smart... 
Clinical trials | Medical equipment | Medical devices | Anaphylaxis | Anxieties | Usability
Journal Article